SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001047469-18-007619
Filing Date
2018-12-12
Accepted
2018-12-12 17:31:32
Documents
9

Document Format Files

Seq Description Document Type Size
1 424B5 a2237337z424b5.htm 424B5 393530
2 G950531.JPG g950531.jpg GRAPHIC 17021
3 G288751.JPG g288751.jpg GRAPHIC 37005
4 G896645.JPG g896645.jpg GRAPHIC 59320
5 G463809.JPG g463809.jpg GRAPHIC 49418
6 G741471.JPG g741471.jpg GRAPHIC 48070
7 G96498.JPG g96498.jpg GRAPHIC 90669
8 G82524.JPG g82524.jpg GRAPHIC 31557
9 G712315.JPG g712315.jpg GRAPHIC 8217
  Complete submission text file 0001047469-18-007619.txt   865636
Mailing Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 87 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 (617) 401-4060
Ra Pharmaceuticals, Inc. (Filer) CIK: 0001481512 (see all company filings)

IRS No.: 262908274 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-221266 | Film No.: 181231636
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1